{"id":"NCT00225732","sponsor":"Cumberland Pharmaceuticals","briefTitle":"Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients","officialTitle":"A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2005-09-26","resultsPosted":"2011-09-15","lastUpdate":"2016-06-22"},"enrollment":319,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"OTHER","name":"Normal saline as placebo comparator","otherNames":["NS"]},{"type":"DRUG","name":"Intravenous ibuprofen","otherNames":["Caldolor"]}],"arms":[{"label":"intravenous ibuprofen","type":"ACTIVE_COMPARATOR"},{"label":"normal saline","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery","primaryOutcome":{"measure":"Change in the Patient Demand for the Narcotic Analgesic, Morphine, Post Surgery","timeFrame":"24 Hours","effectByArm":[{"arm":"Placebo","deltaMin":57,"sd":2.4},{"arm":"800 mg Intravenous Ibuprofen","deltaMin":48.7,"sd":2.3}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":13,"countries":["United States","Australia"]},"refs":{"pmids":["19843482"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":153},"commonTop":["Nausea","Flatulence","Pruritis","Constipation","Vomiting"]}}